1.
Fukuda Y, Araki M, Yamamoto K, Morishita S, Inano T, Misawa K, Ochiai T, Edahiro Y, Imai M, Yasuda H, Gotoh A, Ohsaka A, Komatsu N. Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy. Haematologica [Internet]. 2019Oct.30 [cited 2026Nov.16];104(11):e506-e509. Available from: https://haematologica.org/article/view/9139